Sustained release hormonal preparations. 5. Absorption of 6-methyl-17-alpha-acetoxypregna-4,6-diene-3,20-dione from polydimethylsiloxane implants in vivo.
D000818:Animals; D002214:Capsules; D006224:Cricetinae; D003692:Delayed-Action Preparations; D005260:Female; D008535:Megestrol / Q000008:administration & dosage / Q000378:metabolism / Q000652:urine; D008567:Membranes, Artificial; D011278:Pregnanes / Q000008:administration & dosage*; D011372:Progestins / Q000008:administration & dosage*; D011817:Rabbits; D012828:Silicones
D002214:Capsules; D003692:Delayed-Action Preparations; D008567:Membranes, Artificial; D011278:Pregnanes; D011372:Progestins; D012828:Silicones; D008535:Megestrol